Latest Breaking News On - Session date - Page 5 : comparemela.com

BeyondSpring and Leading Cancer Center to Present Poster at SITC s 38th Annual Meeting

BeyondSpring and Leading Cancer Center to Present Poster at SITC s 38th Annual Meeting
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan diego convention centerSan diegoEli lillyStevenh linBeyondspring incSociety for immunotherapy of cancerUniversity of texas md anderson cancer centerAnnual meetingImmune activationImmune checkpoint blockadeSession dateExhibit halls

Intensity Therapeutics INT230-6 Prolongs Survival Alone or in Combination With Ipilimumab in Adult Patients with Relapsed, Refractory, Metastatic Sarcomas

/PRNewswire/ Intensity Therapeutics, Inc. ("Intensity"), a clinical-stage biotechnology company focused on the discovery and development of proprietary,.

United statesChristian frederick meyerMerck sharpe dohmeChristianf meyerMichael millerBristol myers squibbLewish benderEdna kaplanOttawa hospital research instituteOntario institute of cancer researchDrug administrationPrnewswire intensity therapeutics incAmerican society of clinical oncologyCompany on twitterDevelopment agreementRx communications group

Elevation Oncology Highlights First-in-Human Phase 1 SYSA1801 (EO-3021) Clinical Data to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023

/PRNewswire/ Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies.

United statesChunlei liValerie malyvanh jansenYakun wangElevation oncology incCorporate communications investor relationsAmerican society of clinical oncologyPrnewswire elevation oncology incExchange commissionGroup limitedDrug administrationAmerican societyClinical oncologyChief medical officerElevation oncologyChief scientific officer

Hummingbird Bioscience Announces HMBD-002 Trials in Progress Poster at ASCO Annual Meeting 2023

Hummingbird Bioscience Announces HMBD-002 Trials in Progress Poster at ASCO Annual Meeting 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJerome boyd kirkupMerck co incResearch institute of texasAmerican society of clinical oncologyMerck sharp dohmeAmerican societyClinical oncologyAnnual meetingHummingbird bioscienceChief scientificProgress poster detailsSession trackDevelopmental therapeuticsSession dateBoard number

SpringWorks Therapeutics Announces Presentation of Additional Data from Phase 3 DeFi Trial of Nirogacestat in Adults with Desmoid Tumors at the 2023 ASCO Annual Meeting

- Nirogacestat Treatment Demonstrated Rapid, Sustained and Consistent Reductions in Pain Compared to Placebo Using Multiple Assessment Tools - - Substantial Reductions in MRI-Assessed Tumor Volume. | May 25, 2023

United statesSamantha hilson sandlerJim cassidyFred hutchinson cancer research centerEuropean organization for researchEuropean consensus initiativeDesmoid tumor working groupDesmoid working groupAmerican society of clinical oncologyEuropean society for medical oncology congressSpringworks therapeutics incBone sarcoma groupEuropean commissionDrug administrationDana farber cancer instituteTreatment demonstrated rapid